Gain insight to common pathways that lead to poor outcomes. Guide treatment and get ahead of patient deterioration with risk indices that were developed utilizing more than 150 million hours of de-identified patient data.
Etiometry is the only company in the world with four FDA-cleared risk analytics algorithms for critical care.
Objective and continuous assessment of the risk of patient deterioration, facilitating both escalation and de-escalation decisions
Inadequate Delivery of Oxygen: Etiometry IDO2 Index™
Inadequate Ventilation of Carbon Dioxide:
Etiometry IVCO2 Index™
Etiometry HLA Index™
Etiometry ACD Index™
quality & research
Request highlights of clinical outcomes data associated with Etiometry use
- Etiometry’s IDO2 Index™ is solely indicated for use for adult patients and patients under 12 years with weights above 2 kg.
- Etiometry’s IVCO2 Index™ is solely indicated for use for invasively mechanically ventilated patients 0 days to 12 years.
- The Etiometry Platform is not an active patient monitoring system. It is intended to supplement and not replace any part of the hospital’s device monitoring. Do not rely on the Etiometry Platform as the sole source of patient status information. For prescription use only.